MHRA fees review and uplift consultancy came from Carnall Farrar
- Medicines and Healthcare products Regulatory Agency (MHRA)
- London
- Direct
- 19 March 2026 to 31 May 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) hired Carnall Farrar Ltd, a small business, to help review and raise its fees.
The agency was re-valuing its fees to cover the cost of building up capacity, so it could give industry better services. Carnall Farrar's brief had four strands. It challenged the MHRA's internal model from outside and studied how the market would respond to price. It also worked on SME and voucher scheme design and benchmarked the agency's value proposition.
The MHRA awarded the £77,058 contract directly. The work ran from March 2026 and was due to end in May 2026, feeding into the draft MHRA 2030 strategy.
- What
- Regulatory and competition economics
- Supplier
- Carnall Farrar Ltd
- Value
- £77,058
- How it was bought
- Direct
- Dates and next
- Mar 2026 to May 2026